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OBJECTIVE — To evaluate the prevalence of -cell autoimmunity and the usefulness of a
type 1 diabetes screening in patients with celiac disease.
RESEARCH DESIGN AND METHODS — We measured GAD antibodies (GADAs),
insulinoma-associated protein 2 antigens (IA-2As), and insulin autoantibodies (IAAs) in 188
youngItalianpatientswithceliacdisease(66male[35.1%]).Meanageatceliacdiseasediagnosis
was 5.4 years (0.5–17.1), and mean celiac disease duration was 4.2 years (0–28.8). Celiac
disease was diagnosed by jejunal biopsy after positivity for endomysial and tissue transglutami-
nase antibody was conﬁrmed.
RESULTS — GADAs were positive in seven patients (3.7%), and IA-2As were positive in two
patients. IAAs were negative in all cases. Metabolic evaluation was normal, and no patients
developed diabetes during follow-up. There was no signiﬁcant association among -cell auto-
immunity and sex, age, pubertal stage, family history, or coexistence of other autoimmune
disorders; compliance to a gluten-free diet was conﬁrmed.
CONCLUSIONS — Ourresultsshowedalowprevalenceof-cellautoimmunityanddonot
support a precocious screening for -cell autoimmunity in young celiac disease patients.
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C
eliac disease, whose prevalence in
the general Western population is
about 1%, is associated with other
autoimmune disorders (1). Type 1 diabe-
tes and celiac disease share a prodromic
period, with autoantibodies to islet or gut
antigens. Antibodies to GAD (GADAs), to
insulinoma-associated protein 2 antigen
(IA-2A), and anti-insulin (insulin auto-
antibody[IAA])areusedfortype1diabe-
tes screening; antiendomysial antibodies
(EMAs) and endomysial tissue transglu-
taminase antibodies (tTGAs) are recom-
mendedforceliacdiseasescreening(2,3).
Few reports investigated -cell autoim-
munity in celiac disease patients (4,5).
We evaluated the frequency of -cell au-
toimmunity and the usefulness of type 1
diabetes screening in young celiac disease
patients.
RESEARCH DESIGN AND
METHODS— We measured -cell
autoantibodies in 188 Italian patients
with celiac disease diagnosed by jejunal
biopsyaccordingtoMarshstagingcriteria
after conﬁrmation of EMA and tTGA pos-
itivityandpresentationofvariousdegrees
of symptoms. Gluten-free diet (GFD)
compliance was evaluated by means of
EMA and tTGA.
IgA tTGA was detected using en-
zyme-linked immunosorbent assay, and
IgA EMA by indirect immunoﬂuorescence.
All samples were analyzed for GADA, IA-
2A, and IAA with radiobinding assays (6).
Personalandfamilyhistoriesforotherauto-
immune disorders were recorded.
Comparison of qualitative data among
various groups was made by a 
2 test or
Fisher’sexacttest.Alltestsweretwosided;a
Pvalue0.05wassigniﬁcant.Statistica(re-
lease6;StatSoft,Tulsa,OK)wasusedforall
of the analyses. Comparison of celiac dis-
ease duration between the two groups of
patients (positive vs. negative to -cell au-
toantibodies) was performed by means of
the parametric Mann-Whitney U test be-
cause the normality assumption of the
evaluable variable was not fulﬁlled.
RESULTS— Characteristics of the
study population are reported in Table 1.
Celiac disease was diagnosed in 78.7% of
children with classical symptoms, in
7.5% with atypical symptoms, and in
13.8% after the screening procedure.
We found concomitant autoimmune
thyroid disease (ATD) in 5.6% of the pa-
tients. No patients had juvenile idiopathic
arthritis, atrophic gastritis, Addison’s dis-
ease, or vitiligo. A positive history of one or
more autoimmune disorders was found in
35.6%ofthefamilies(celiacdiseasein26.6,
ATD in 9.6, and both type 1 diabetes and
juvenile idiopathic arthritis in 2.3%).
We found positivity for diabetes-
related autoantibodies in nine patients
(4.8% [95% CI 2.2–8.9]): seven patients
showed positivity for GADA (3.7% [1.5–
7.5]) and two patients for IA-2A (1.1%
[0.1–3.8]), whereas no patients presented
with IAA or were positive for two autoanti-
bodies. All nine positive patients had nor-
mal fasting plasma glucose, A1C levels,
and  120 plasma glucose after the oral
glucose tolerance test. The intravenous glu-
cose tolerance test showed ﬁrst-phase insu-
lin response less than the ﬁrst percentile
only in three of nine cases. No patients de-
veloped clinical type 1 diabetes after a
3-year follow-up.
We found no signiﬁcant association
among -cell autoimmunity and sex, age
at diagnosis (10 vs. 10 years), family
history of autoimmune disorders, con-
comitant ATD, GFD compliance, and
Tanner pubertal stage. No relationships
were observed between celiac disease du-
ration and positivity to -cell autoanti-
bodies (P  0.79).
HLA class II typing (DQ2 and DQ8
alleles) was performed in 80 of 188 celiac
diseasepatients(42.5%).Amongthenine
patients with -cell autoantibodies, HLA
typing was performed in eight cases. We
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in one case, and HLA-DQ2/DQ8 in one
case. Among the remaining 72 patients
without -cell autoantibodies, we found
HLA-DQ2 in 69 cases, HLA-DQ8 in two
cases, and HLA-DQ2/DQ8 in one case.
CONCLUSIONS — Alowprevalence
of diabetes-related antibodies was ob-
served, as well as no association with
other autoimmune disorders. In adults,
celiac disease is associated with several
autoimmune disorders (mostly type 1 di-
abetes and thyroid diseases). Otherwise,
in pediatric celiac disease patients, the
rate and signiﬁcance of diabetes-related
antibodies yielded conﬂicting results (7).
Di Mario et al. (8) evaluated IAAs and
islet cell antibodies (ICAs) in children
with newly diagnosed celiac disease on a
gluten-containing diet, in those with
long-standing celiac disease following
GFD,andincontrolgroupsandraisedthe
questionastowhethertheyarepredictive
ofsubclinicaldiabetesorwhethertheyare
indicators of a general autoimmune dia-
thesis. Karagiozoglou-Lampoudi et al. (9)
reported no positivity for ICA in pediatric
celiac disease patients. Galli-Tsinopoulou
etal.(10)showedGADAandIA-2Ain23%
ofceliacdiseasepatientsandrecommended
screening for -cell autoimmunity.
In a retrospective study of 90 young
Italian patients with celiac disease, the
prevalence of diabetes-related autoanti-
bodies was 11.1% and related to gluten
exposure (7). Similarly, in an Italian large
case series of adult celiac disease patients,
a high prevalence (9%) of one diabetes-
related autoantibody (ICA, IA-2A, or
GADA) was observed independently of
GFD compliance (11). Despite this high
rate of diabetes-related autoimmunity, no
incident cases of diabetes were reported,
supporting the role of common genetic
susceptibility to both diseases and factors
involved in gut permeability (7).
Conﬂicting data about prevalence of
diabetes-related autoantibodies in celiac
disease patients could be due to the im-
provement of laboratory methods, which
excluded false-positive data.
In young celiac disease patients, the
length of gluten exposure could inﬂuence
the development of other autoimmune
disorders (7). Bonamico et al. (12) re-
ported at least one endocrine-related
serum autoantibody (either ICA or anti-
thyroid microsomal antibody) in 50%
of adolescents with undiagnosed celiac
diseasebutinonly12%ofceliacdisease
patients on GFD, suggesting that these
autoantibodies could be partly gluten
dependent.
Abnormal regulation of intestinal per-
meability and increased autoantibody pro-
duction in the setting of chronic gut
inﬂammation are trigger factors for the de-
velopment of autoimmune response (12).
Recent evidence suggests that gluten-
induced upregulation of zonulin, an intes-
tinal peptide involved in the regulation of
guttightjunctions,couldberesponsiblefor
the aberrant increase in gut permeability
otherwisefoundintype1diabetes(13).The
gutimmunesystemincludesthemajorityof
the total lymphoid tissue in humans; there-
fore,adetrimentalresponsetodietarycom-
ponents would have repercussions
throughout the organism, carried either by
immune cells or immune mediators re-
leased from the gut (14).
Laadhar et al. (4) did not ﬁnd differ-
encesinprevalenceof-cellautoantibodies
betweenchildrenwithnewlydiagnosedce-
liac disease and control groups and con-
cluded that screening for diabetes-related
autoantibodiesisnotjustiﬁed.Thisopinion
has been shared by Fanciulli et al. (5), who
did not recommend regular screening for
-cellautoimmunityinallceliacdiseasepa-
tientsbecauseoflowprevalenceofdiabetes-
related autoimmunity in young celiac
disease patients.
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